Webinar | Protocol Design Drives Comparator Sourcing Cost

Date: Tuesday, August 7, 2018
Time: 11am EDT | 8am PDT | 4pm BST | 5pm CEST 

Register Today

Clinical trial protocol design can have a significant positive or negative impact on the eventual commercial drug sourcing strategy needed to successfully acquire the comparator drugs needed to execute the study. Early input into the development of the protocol—which considers the need to source commercial products for use in the study—can potentially impact the costs, timelines, operational complexity, and overall risk incurred when sourcing comparators.

How detailed should the description of the needed comparator(s) be in the protocol? Should specific countries of origin should be named? Are there other drug characteristic variables that should be considered? Should sourcing be done centrally or regionally? This webcast will address these and other questions that should be considered before a trial protocol is finalized.

Key Learning Objectives:

  • Understand why input into protocol is highly desired and can reduce costs, timelines, operational complexity, and risk
  • Discover how consulting with an expert early is essential to support the collection of the best research and enhance the ability to consider all possible options
  • Learn ways to ensure protocol design flexibility to support smarter commercial product sourcing


Keith Krenitsky
Global Director, Commercial Drug Sourcing
Catalent Pharma Solutions

Shaila Saeed Strategic Advisor
Global Commercial Drug Sourcing
Catalent Pharma Solutions

Register Today